Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan
Background Although bone and soft tissue sarcoma is recognized as a rare cancer that originates throughout the body, few comprehensive reports regarding it have been published in Japan. Patients and methods Bone and soft tissue sarcomas were tabulated from the Cancer Registries at eight university h...
Gespeichert in:
| Veröffentlicht in: | International journal of clinical oncology 2024-03, Vol.29 (3), p.345-353 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 353 |
|---|---|
| container_issue | 3 |
| container_start_page | 345 |
| container_title | International journal of clinical oncology |
| container_volume | 29 |
| creator | Nakamura, Nobuko Hasebe, Shinji Yamanaka, Shintaro Fujii, Tomomi Fujibuchi, Taketsugu Kitani, Teruki Takeuchi, Kazuto Sato, Yasushi Shindo, Yoshitaro Ozaki, Toshifumi Nishisho, Toshihiro Tabata, Masahiro Yakushijin, Yoshihiro |
| description | Background
Although bone and soft tissue sarcoma is recognized as a rare cancer that originates throughout the body, few comprehensive reports regarding it have been published in Japan.
Patients and methods
Bone and soft tissue sarcomas were tabulated from the Cancer Registries at eight university hospitals in the Chugoku–Shikoku region. Prognostic factors in cases were extracted in a single facility and have been analyzed.
Results
From 2016 to 2019, 3.4 patients with bone and soft tissue sarcomas per a general population of 100,000 were treated at eight university hospitals. The number of patients who underwent multidisciplinary treatment involving collaboration among multiple clinical departments has been increasing recently. In the analysis carried out at a single institute (Ehime University Hospital), a total of 127 patients (male/female: 54/73) with an average age of 67.0 y (median 69.5) were treated for four years, with a 5-year survival rate of 55.0%. In the analysis of prognostic factors by multivariate, disease stage and its relative treatment, renal function (creatinine), and a patient’s ability of self-judgment, and a patient’s mobility and physical capability were associated with patient prognosis regarding bone and soft tissue sarcomas. Interestingly, age did not affect the patient’s prognosis (> 70 vs ≦ 70).
Conclusions
Physical and social factors may affect the prognosis of patients with bone and soft tissue sarcomas, especially those living in non-urban areas. |
| doi_str_mv | 10.1007/s10147-023-02453-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2908125345</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2930094858</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-36731da46a7b1d875d5f54817b4a493197fe6686370576899b4211a04f1d8cbf3</originalsourceid><addsrcrecordid>eNp9kLtKBTEQhoMoXo6-gIUEbGxWc0-2FPGKYKOtIbubyMrZ5JjZLXx7cy4qWFiEhMw3_wwfQseUnFNC9AVQQoWuCOPlCMkrsYX2qeC60lqz7fLmgla1YnIPHQC8E0K1kmwX7XFDpWTc7KPX5-zdOPg4Anaxw4uc3mKCsW9xcO2YMuCQMm5S9Ks6pDDisQeYPAaX2zQ43EccU6ym3LiIXcmD5deDW7h4iHaCm4M_2twz9HJz_Xx1Vz0-3d5fXT5WLWdqrLjSnHZOKKcb2hktOxmkMFQ3woma01oHr5RRXBOplanrRjBKHRGh0G0T-AydrXPL_h-Th9EOPbR-PnfRpwksq4mhTPJiaYZO_6DvacqxbFcoTkgtjDSFYmuqzQkg-2AXuR9c_rSU2KV9u7Zvi327sm9FaTrZRE_N4Luflm_dBeBrAEopvvn8O_uf2C_f544M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2930094858</pqid></control><display><type>article</type><title>Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan</title><source>SpringerNature Journals</source><creator>Nakamura, Nobuko ; Hasebe, Shinji ; Yamanaka, Shintaro ; Fujii, Tomomi ; Fujibuchi, Taketsugu ; Kitani, Teruki ; Takeuchi, Kazuto ; Sato, Yasushi ; Shindo, Yoshitaro ; Ozaki, Toshifumi ; Nishisho, Toshihiro ; Tabata, Masahiro ; Yakushijin, Yoshihiro</creator><creatorcontrib>Nakamura, Nobuko ; Hasebe, Shinji ; Yamanaka, Shintaro ; Fujii, Tomomi ; Fujibuchi, Taketsugu ; Kitani, Teruki ; Takeuchi, Kazuto ; Sato, Yasushi ; Shindo, Yoshitaro ; Ozaki, Toshifumi ; Nishisho, Toshihiro ; Tabata, Masahiro ; Yakushijin, Yoshihiro</creatorcontrib><description>Background
Although bone and soft tissue sarcoma is recognized as a rare cancer that originates throughout the body, few comprehensive reports regarding it have been published in Japan.
Patients and methods
Bone and soft tissue sarcomas were tabulated from the Cancer Registries at eight university hospitals in the Chugoku–Shikoku region. Prognostic factors in cases were extracted in a single facility and have been analyzed.
Results
From 2016 to 2019, 3.4 patients with bone and soft tissue sarcomas per a general population of 100,000 were treated at eight university hospitals. The number of patients who underwent multidisciplinary treatment involving collaboration among multiple clinical departments has been increasing recently. In the analysis carried out at a single institute (Ehime University Hospital), a total of 127 patients (male/female: 54/73) with an average age of 67.0 y (median 69.5) were treated for four years, with a 5-year survival rate of 55.0%. In the analysis of prognostic factors by multivariate, disease stage and its relative treatment, renal function (creatinine), and a patient’s ability of self-judgment, and a patient’s mobility and physical capability were associated with patient prognosis regarding bone and soft tissue sarcomas. Interestingly, age did not affect the patient’s prognosis (> 70 vs ≦ 70).
Conclusions
Physical and social factors may affect the prognosis of patients with bone and soft tissue sarcomas, especially those living in non-urban areas.</description><identifier>ISSN: 1341-9625</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-023-02453-4</identifier><identifier>PMID: 38155238</identifier><language>eng</language><publisher>Singapore: Springer Nature Singapore</publisher><subject>Cancer Research ; Creatinine ; Hospitals ; Medical prognosis ; Medicine ; Medicine & Public Health ; Oncology ; Original Article ; Patients ; Prognosis ; Renal function ; Sarcoma ; Social factors ; Soft tissue sarcoma ; Surgical Oncology ; Urban areas</subject><ispartof>International journal of clinical oncology, 2024-03, Vol.29 (3), p.345-353</ispartof><rights>The Author(s) under exclusive licence to Japan Society of Clinical Oncology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-36731da46a7b1d875d5f54817b4a493197fe6686370576899b4211a04f1d8cbf3</cites><orcidid>0000-0001-6001-746X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10147-023-02453-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10147-023-02453-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38155238$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakamura, Nobuko</creatorcontrib><creatorcontrib>Hasebe, Shinji</creatorcontrib><creatorcontrib>Yamanaka, Shintaro</creatorcontrib><creatorcontrib>Fujii, Tomomi</creatorcontrib><creatorcontrib>Fujibuchi, Taketsugu</creatorcontrib><creatorcontrib>Kitani, Teruki</creatorcontrib><creatorcontrib>Takeuchi, Kazuto</creatorcontrib><creatorcontrib>Sato, Yasushi</creatorcontrib><creatorcontrib>Shindo, Yoshitaro</creatorcontrib><creatorcontrib>Ozaki, Toshifumi</creatorcontrib><creatorcontrib>Nishisho, Toshihiro</creatorcontrib><creatorcontrib>Tabata, Masahiro</creatorcontrib><creatorcontrib>Yakushijin, Yoshihiro</creatorcontrib><title>Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><addtitle>Int J Clin Oncol</addtitle><description>Background
Although bone and soft tissue sarcoma is recognized as a rare cancer that originates throughout the body, few comprehensive reports regarding it have been published in Japan.
Patients and methods
Bone and soft tissue sarcomas were tabulated from the Cancer Registries at eight university hospitals in the Chugoku–Shikoku region. Prognostic factors in cases were extracted in a single facility and have been analyzed.
Results
From 2016 to 2019, 3.4 patients with bone and soft tissue sarcomas per a general population of 100,000 were treated at eight university hospitals. The number of patients who underwent multidisciplinary treatment involving collaboration among multiple clinical departments has been increasing recently. In the analysis carried out at a single institute (Ehime University Hospital), a total of 127 patients (male/female: 54/73) with an average age of 67.0 y (median 69.5) were treated for four years, with a 5-year survival rate of 55.0%. In the analysis of prognostic factors by multivariate, disease stage and its relative treatment, renal function (creatinine), and a patient’s ability of self-judgment, and a patient’s mobility and physical capability were associated with patient prognosis regarding bone and soft tissue sarcomas. Interestingly, age did not affect the patient’s prognosis (> 70 vs ≦ 70).
Conclusions
Physical and social factors may affect the prognosis of patients with bone and soft tissue sarcomas, especially those living in non-urban areas.</description><subject>Cancer Research</subject><subject>Creatinine</subject><subject>Hospitals</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Renal function</subject><subject>Sarcoma</subject><subject>Social factors</subject><subject>Soft tissue sarcoma</subject><subject>Surgical Oncology</subject><subject>Urban areas</subject><issn>1341-9625</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kLtKBTEQhoMoXo6-gIUEbGxWc0-2FPGKYKOtIbubyMrZ5JjZLXx7cy4qWFiEhMw3_wwfQseUnFNC9AVQQoWuCOPlCMkrsYX2qeC60lqz7fLmgla1YnIPHQC8E0K1kmwX7XFDpWTc7KPX5-zdOPg4Anaxw4uc3mKCsW9xcO2YMuCQMm5S9Ks6pDDisQeYPAaX2zQ43EccU6ym3LiIXcmD5deDW7h4iHaCm4M_2twz9HJz_Xx1Vz0-3d5fXT5WLWdqrLjSnHZOKKcb2hktOxmkMFQ3woma01oHr5RRXBOplanrRjBKHRGh0G0T-AydrXPL_h-Th9EOPbR-PnfRpwksq4mhTPJiaYZO_6DvacqxbFcoTkgtjDSFYmuqzQkg-2AXuR9c_rSU2KV9u7Zvi327sm9FaTrZRE_N4Luflm_dBeBrAEopvvn8O_uf2C_f544M</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Nakamura, Nobuko</creator><creator>Hasebe, Shinji</creator><creator>Yamanaka, Shintaro</creator><creator>Fujii, Tomomi</creator><creator>Fujibuchi, Taketsugu</creator><creator>Kitani, Teruki</creator><creator>Takeuchi, Kazuto</creator><creator>Sato, Yasushi</creator><creator>Shindo, Yoshitaro</creator><creator>Ozaki, Toshifumi</creator><creator>Nishisho, Toshihiro</creator><creator>Tabata, Masahiro</creator><creator>Yakushijin, Yoshihiro</creator><general>Springer Nature Singapore</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6001-746X</orcidid></search><sort><creationdate>20240301</creationdate><title>Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan</title><author>Nakamura, Nobuko ; Hasebe, Shinji ; Yamanaka, Shintaro ; Fujii, Tomomi ; Fujibuchi, Taketsugu ; Kitani, Teruki ; Takeuchi, Kazuto ; Sato, Yasushi ; Shindo, Yoshitaro ; Ozaki, Toshifumi ; Nishisho, Toshihiro ; Tabata, Masahiro ; Yakushijin, Yoshihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-36731da46a7b1d875d5f54817b4a493197fe6686370576899b4211a04f1d8cbf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cancer Research</topic><topic>Creatinine</topic><topic>Hospitals</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Renal function</topic><topic>Sarcoma</topic><topic>Social factors</topic><topic>Soft tissue sarcoma</topic><topic>Surgical Oncology</topic><topic>Urban areas</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakamura, Nobuko</creatorcontrib><creatorcontrib>Hasebe, Shinji</creatorcontrib><creatorcontrib>Yamanaka, Shintaro</creatorcontrib><creatorcontrib>Fujii, Tomomi</creatorcontrib><creatorcontrib>Fujibuchi, Taketsugu</creatorcontrib><creatorcontrib>Kitani, Teruki</creatorcontrib><creatorcontrib>Takeuchi, Kazuto</creatorcontrib><creatorcontrib>Sato, Yasushi</creatorcontrib><creatorcontrib>Shindo, Yoshitaro</creatorcontrib><creatorcontrib>Ozaki, Toshifumi</creatorcontrib><creatorcontrib>Nishisho, Toshihiro</creatorcontrib><creatorcontrib>Tabata, Masahiro</creatorcontrib><creatorcontrib>Yakushijin, Yoshihiro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakamura, Nobuko</au><au>Hasebe, Shinji</au><au>Yamanaka, Shintaro</au><au>Fujii, Tomomi</au><au>Fujibuchi, Taketsugu</au><au>Kitani, Teruki</au><au>Takeuchi, Kazuto</au><au>Sato, Yasushi</au><au>Shindo, Yoshitaro</au><au>Ozaki, Toshifumi</au><au>Nishisho, Toshihiro</au><au>Tabata, Masahiro</au><au>Yakushijin, Yoshihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><addtitle>Int J Clin Oncol</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>29</volume><issue>3</issue><spage>345</spage><epage>353</epage><pages>345-353</pages><issn>1341-9625</issn><eissn>1437-7772</eissn><abstract>Background
Although bone and soft tissue sarcoma is recognized as a rare cancer that originates throughout the body, few comprehensive reports regarding it have been published in Japan.
Patients and methods
Bone and soft tissue sarcomas were tabulated from the Cancer Registries at eight university hospitals in the Chugoku–Shikoku region. Prognostic factors in cases were extracted in a single facility and have been analyzed.
Results
From 2016 to 2019, 3.4 patients with bone and soft tissue sarcomas per a general population of 100,000 were treated at eight university hospitals. The number of patients who underwent multidisciplinary treatment involving collaboration among multiple clinical departments has been increasing recently. In the analysis carried out at a single institute (Ehime University Hospital), a total of 127 patients (male/female: 54/73) with an average age of 67.0 y (median 69.5) were treated for four years, with a 5-year survival rate of 55.0%. In the analysis of prognostic factors by multivariate, disease stage and its relative treatment, renal function (creatinine), and a patient’s ability of self-judgment, and a patient’s mobility and physical capability were associated with patient prognosis regarding bone and soft tissue sarcomas. Interestingly, age did not affect the patient’s prognosis (> 70 vs ≦ 70).
Conclusions
Physical and social factors may affect the prognosis of patients with bone and soft tissue sarcomas, especially those living in non-urban areas.</abstract><cop>Singapore</cop><pub>Springer Nature Singapore</pub><pmid>38155238</pmid><doi>10.1007/s10147-023-02453-4</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6001-746X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1341-9625 |
| ispartof | International journal of clinical oncology, 2024-03, Vol.29 (3), p.345-353 |
| issn | 1341-9625 1437-7772 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2908125345 |
| source | SpringerNature Journals |
| subjects | Cancer Research Creatinine Hospitals Medical prognosis Medicine Medicine & Public Health Oncology Original Article Patients Prognosis Renal function Sarcoma Social factors Soft tissue sarcoma Surgical Oncology Urban areas |
| title | Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T18%3A56%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatments%20and%20prognostic%20factors%20for%20bone%20and%20soft%20tissue%20sarcoma%20in%20non-urban%20areas%20in%20Japan&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Nakamura,%20Nobuko&rft.date=2024-03-01&rft.volume=29&rft.issue=3&rft.spage=345&rft.epage=353&rft.pages=345-353&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-023-02453-4&rft_dat=%3Cproquest_cross%3E2930094858%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2930094858&rft_id=info:pmid/38155238&rfr_iscdi=true |